Samuel D. Rabkin

Harvard University — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

62h-index14.5kcitations292works8.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(224), Herpesvirus Infections and Treatments(125), CAR-T cell therapy research(68), Viral Infectious Diseases and Gene Expression in Insects(65), Cancer Research and Treatments(65)

Publications292 total

EXTH-45. Oncolytic Herpes Simplex Virus Synergizes with DNA-PKcs Inhibitors to Treat Glioblastoma
Neuro-Oncology·2025Open Access
EXTH-91. Leveraging the cGAS-STING pathway to modulate the tumor microenvironment and enhance immunotherapies in glioblastoma
Neuro-Oncology·2025Open Access
P160 INTERLEUKIN-17, INTERLEUKIN-18, T REGULATORY CELLS AND T-HELPER 17 (TH17) CELLS PLAY A ROLE IN HEART FAILURE: A SYSTEMATIC REVIEW AND META-ANALYSIS
Canadian Journal of Cardiology·2025
Promoting the therapeutic potential of interleukin-7 (IL-7) by expression in viral vectors
Cancer Gene Therapy·2025· 3 citedOpen Access
MODULATING AUTOPHAGY USING ONCOLYTIC HERPES SIMPLEX VIRUSES AND METFORMIN FOR IMMUNOTHERAPY IN GLIOBLASTOMA
Neuro-Oncology·2025Open Access
Understanding the interplay between oHSV and the host immune system: Implications for therapeutic oncolytic virus development
Molecular Therapy·2024· 6 cited
Immunocompetent murine glioblastoma stem-like cell models exhibiting distinct phenotypes
Neuro-Oncology Advances·2024Open Access
Safety of non-replicative and oncolytic replication-selective HSV vectors
Trends in Molecular Medicine·2024· 14 citedOpen Access
Cytokine-armed oncolytic herpes simplex viruses: a game-changer in cancer immunotherapy?
Journal for ImmunoTherapy of Cancer·2024· 23 citedOpen Access
Oncolytic herpes simplex virus expressing IL-2 controls glioblastoma growth and improves survival
Journal for ImmunoTherapy of Cancer·2024· 38 citedOpen Access
MODL-49. NEW MURINE GLIOBLASTOMA STEM-LIKE CELL MODELS
Neuro-Oncology·2023Open Access
Photodynamic augmentation of oncolytic virus therapy for central nervous system malignancies
Cancer Letters·2023· 17 citedOpen Access
Viral Vectors Expressing Interleukin 2 for Cancer Immunotherapy
Human Gene Therapy·2023· 30 citedOpen Access
Oncolytic herpes simplex viruses for the treatment of glioma and targeting glioblastoma stem-like cells
Frontiers in Cellular and Infection Microbiology·2023· 28 citedOpen Access
Figure S2 from Combinatorial Effects of VEGFR Kinase Inhibitor Axitinib and Oncolytic Virotherapy in Mouse and Human Glioblastoma Stem-Like Cell Models
2023Open Access
Figure S5 from Combinatorial Effects of VEGFR Kinase Inhibitor Axitinib and Oncolytic Virotherapy in Mouse and Human Glioblastoma Stem-Like Cell Models
2023Open Access
Figure S3 from Combinatorial Effects of VEGFR Kinase Inhibitor Axitinib and Oncolytic Virotherapy in Mouse and Human Glioblastoma Stem-Like Cell Models
2023Open Access
Supplementary Figure 1 from Enhanced Antitumor Efficacy of Low-Dose Etoposide with Oncolytic Herpes Simplex Virus in Human Glioblastoma Stem Cell Xenografts
2023Open Access
Supplementary Table S1 from Modification of Extracellular Matrix Enhances Oncolytic Adenovirus Immunotherapy in Glioblastoma
2023Open Access
Data from A Novel Oncolytic Herpes Simplex Virus that Synergizes with Phosphoinositide 3-kinase/Akt Pathway Inhibitors to Target Glioblastoma Stem Cells
2023Open Access
page 1 of 15Next →

Frequent Co-authors

Robert L. Martuza(26), Hiroaki Wakimoto(12), Tomoki Todo(9), R L Martuza(6), Masahiro Toda(5), Ryuichi Kanai(5), Periasamy Sundaresan(5), William D. Hunter(4), Frank Feigenbaum(4), Takahito Yazaki(4), R L Martuza(4), Anoop P. Patel(3), William T. Curry(3), David N. Louis(3), Toshihiro Mineta(3), Cécile Zaupa(3), Toshihiko Kuroda(3), Ta‐Chiang Liu(3), Deva S. Jeyaretna(3), Tooba A. Cheema(3)